We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Multianalyte Quality Control Introduced for NAT Labs

By LabMedica International staff writers
Posted on 27 Apr 2009
A liquid stable, unassayed, multianalyte, third party quality control is available for nucleic acid testing (NAT) labs.

The product, called AmpliTrol III, was designed for use with qualitative in vitro diagnostic procedures for the detection of Human Immunodeficiency Virus, Type 1 (HIV-1), Hepatitis B Virus (HBV), and Hepatitis C Virus (HCV) nucleic acids in human serum or plasma. More...
The new configuration of AmpliTrol III has 60-day open-vial stability when stored at 2-8 ºC. Routine use provides laboratories with the means to monitor assay performance and assure quality on an ongoing basis.

Introduced by Bio-Rad (Hercules, CA, USA), AmpliTrol III is a full process positive control used in the same manner as a patient specimen to monitor sample preparation, amplification, and detection procedures. It is compatible with many commercially available NAT systems, including the Roche (Basel, Switzerland) Cobas AmpliScreen HIV-1 v1.5, Roche AmpliScreen HBV, Roche AmpliScreen HCV v2.0, and Chiron (Emeryville, CA, USA) Procleix HIV-1/HCV assays.

Bio-Rad Laboratories, Inc. is a manufacturer and distributor of life science clinical diagnostics and research products.

Related Links:

Bio-Rad
Roche
Chiron



Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
MTBC DNA Test
MOLgen DNA MBTC Kit
New
HIV-1 Molecular Diagnostic Assay
AltoStar HIV RT-PCR Kit 1.5
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Original illustration showing how exposure-linked mutation patterns may influence tumor immune visibility (Photo courtesy of Máté Manczinger, HUN-REN Szeged BRC)

Cancer Mutation ‘Fingerprints’ to Improve Prediction of Immunotherapy Response

Cancer cells accumulate thousands of genetic mutations, but not all mutations affect tumors in the same way. Some make cancer cells more visible to the immune system, while others allow tumors to evade... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.